Natural biomolecules and derivatives as anticancer immunomodulatory agents.
EGCG
STAT3
anticancer phytochemicals
artemisinin derivatives
berberine
curcumin
graviola
triptolide derivatives
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
14
10
2022
accepted:
05
12
2022
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
28
1
2023
Statut:
epublish
Résumé
Despite advancements in chemotherapy, the issue of resistance and non-responsiveness to many chemotherapeutic drugs that are currently in clinical use still remains. Recently, cancer immunotherapy has gathered attention as a novel treatment against select cancers. Immunomodulation is also emerging as an effective strategy to improve efficacy. Natural phytochemicals, with known anticancer properties, been reported to mediate their effects by modulating both traditional cancer pathways and immunity. The mechanism of phytochemical mediated-immunomodulatory activity may be attributed to the remodeling of the tumor immunosuppressive microenvironment and the sensitization of the immune system. This allows for improved recognition and targeting of cancer cells by the immune system and synergy with chemotherapeutics. In this review, we will discuss several well-known plant-derived biomolecules and examine their potential as immunomodulators, and therefore, as novel immunotherapies for cancer treatment.
Identifiants
pubmed: 36700235
doi: 10.3389/fimmu.2022.1070367
pmc: PMC9868674
doi:
Substances chimiques
Immunomodulating Agents
0
Immunologic Factors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1070367Informations de copyright
Copyright © 2023 Bernitsa, Dayan, Stephanou, Tzvetanova and Patrikios.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Integr Cancer Ther. 2020 Jan-Dec;19:1534735419900930
pubmed: 32493124
Carcinogenesis. 2015 Jun;36(6):656-65
pubmed: 25863125
Life Sci. 2021 Sep 15;281:119754
pubmed: 34174323
Lancet. 2000 Nov 25;356(9244):1795-9
pubmed: 11117911
Environ Sci Pollut Res Int. 2019 May;26(15):15209-15217
pubmed: 30924043
Braz J Med Biol Res. 2019;52(5):e7992
pubmed: 31038546
Gynecol Oncol. 2013 Nov;131(2):357-61
pubmed: 23988418
Phytomedicine. 2021 Dec 22;99:153904
pubmed: 35231825
J Biomed Sci. 2019 Oct 20;26(1):78
pubmed: 31629410
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
Front Immunol. 2021 Jun 23;12:687669
pubmed: 34248973
Biochem Biophys Res Commun. 2020 Jun 18;527(1):283-288
pubmed: 32446381
Cancer Lett. 2012 Oct 1;323(1):29-40
pubmed: 22475682
Thorac Cancer. 2020 Aug;11(8):2316-2324
pubmed: 32657048
Asian Pac J Cancer Prev. 2021 Jan 01;22(1):139-143
pubmed: 33507691
J Immunol. 2003 Oct 1;171(7):3863-71
pubmed: 14500688
Med Oncol. 2010 Sep;27(3):919-25
pubmed: 19757213
Int J Oncol. 2016 Apr;48(4):1519-30
pubmed: 26821279
J Nat Prod. 2016 Mar 25;79(3):629-61
pubmed: 26852623
BMC Pulm Med. 2021 Jan 6;21(1):9
pubmed: 33407290
Indian J Dent Res. 2020 Sep-Oct;31(5):718-727
pubmed: 33433509
Semin Immunol. 2020 Feb;47:101391
pubmed: 31952903
Front Pharmacol. 2020 Mar 03;11:185
pubmed: 32194416
Support Care Cancer. 2018 May;26(5):1543-1552
pubmed: 29192329
Curr Drug Targets. 2020;21(13):1385-1393
pubmed: 32564751
Mol Med Rep. 2017 Sep;16(3):3475-3481
pubmed: 28713965
J Dermatol Sci. 2020 Sep;99(3):193-202
pubmed: 32859456
PLoS One. 2016 Jan 19;11(1):e0147157
pubmed: 26784960
J Immunol. 2018 Jan 15;200(2):422-431
pubmed: 29311384
Gynecol Oncol. 2020 Apr;157(1):188-194
pubmed: 32005582
Cancer Res. 2005 Dec 1;65(23):10854-61
pubmed: 16322232
Exp Cell Res. 2018 Oct 15;371(2):409-416
pubmed: 30179602
Molecules. 2022 Aug 11;27(16):
pubmed: 36014370
Biosci Rep. 2020 Jun 26;40(6):
pubmed: 32452511
Cancer. 2013 Jan 15;119(2):363-70
pubmed: 22760587
Drug Metab Dispos. 2006 Dec;34(12):2064-72
pubmed: 16956957
J Nat Prod. 2016 Mar 25;79(3):616-28
pubmed: 26900761
Mol Carcinog. 2018 Jun;57(6):807-814
pubmed: 29500880
BMC Complement Med Ther. 2020 Dec 10;20(1):375
pubmed: 33302945
Environ Toxicol. 2017 Mar;32(3):845-855
pubmed: 27200496
Int J Mol Sci. 2019 Apr 12;20(8):
pubmed: 31013716
Biomed Pharmacother. 2021 Jan;133:111057
pubmed: 33378962
PLoS One. 2015 May 08;10(5):e0123478
pubmed: 25954974
Gastroenterol Rep (Oxf). 2020 Dec 03;9(1):59-70
pubmed: 33747527
J Cell Physiol. 2019 Nov;234(11):21126-21134
pubmed: 31037726
Redox Biol. 2017 Apr;11:254-262
pubmed: 28012440
Cancer Cell Int. 2020 Dec 9;20(1):592
pubmed: 33298057
Nutr Cancer. 2015;67(8):1293-304
pubmed: 26492225
Int J Oncol. 2022 Jul;61(1):
pubmed: 35621145
Chem Biol Interact. 2020 Nov 1;331:109273
pubmed: 33002460
J Med Chem. 2017 Mar 9;60(5):1620-1637
pubmed: 28074653
Semin Cancer Biol. 2022 May;80:256-275
pubmed: 32461153
Biochem Pharmacol. 2018 Apr;150:72-85
pubmed: 29360439
Free Radic Biol Med. 2020 Dec;161:175-186
pubmed: 33069855
J Biomed Res. 2021 Jul 28;35(4):327-338
pubmed: 34421008
J Clin Invest. 2015 Sep;125(9):3338-46
pubmed: 26241053
Pharm Biol. 2016 Dec;54(12):3040-3045
pubmed: 27450387
J Nanobiotechnology. 2021 Nov 8;19(1):360
pubmed: 34749742
Trends Cancer. 2020 Jun;6(6):518-532
pubmed: 32460005
Cancer Lett. 2012 Jun 28;319(2):203-213
pubmed: 22306340
Cancer Cell. 2015 Apr 13;27(4):462-72
pubmed: 25858805
Am J Clin Oncol. 2016 Feb;39(1):98-106
pubmed: 26558876
Phytomedicine. 2015 Oct 15;22(11):1045-54
pubmed: 26407947
Am J Chin Med. 2015;43(7):1487-502
pubmed: 26503561
Planta Med. 2013 Oct;79(15):1401-7
pubmed: 23975869
Front Pharmacol. 2018 Aug 21;9:557
pubmed: 30186157
Front Cell Dev Biol. 2022 Feb 11;10:757137
pubmed: 35223828
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4275-80
pubmed: 20160101
J Nutr. 2019 Jul 1;149(7):1133-1139
pubmed: 31132111
Nat Struct Mol Biol. 2004 Apr;11(4):380-1
pubmed: 15024383
Drug Des Devel Ther. 2018 Sep 25;12:3199-3209
pubmed: 30288024
Gynecol Oncol. 2012 Feb;124(2):192-8
pubmed: 22040834
J Pers Med. 2022 Aug 19;12(8):
pubmed: 36013283
Oncol Rep. 2010 Mar;23(3):671-6
pubmed: 20127005
Biochem Biophys Res Commun. 2012 Oct 5;426(4):480-5
pubmed: 22960171
Anticancer Res. 2011 Dec;31(12):4417-22
pubmed: 22199309
Breast Cancer Res Treat. 2017 Jul;164(2):359-369
pubmed: 28439738
Biomed Pharmacother. 2018 Oct;106:1307-1316
pubmed: 30119201
EMBO J. 1992 Nov;11(11):3887-95
pubmed: 1396582
Front Pharmacol. 2020 Dec 09;11:616251
pubmed: 33362566
Mol Cell Biochem. 2022 Sep 16;:
pubmed: 36112238
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):267-275
pubmed: 31926918
Pharmacol Rep. 2021 Apr;73(2):650-663
pubmed: 33609273
Asian Pac J Cancer Prev. 2022 Oct 01;23(10):3379-3386
pubmed: 36308362
Cancer Lett. 2008 Nov 8;270(2):337-41
pubmed: 18572307
iScience. 2022 Jul 20;25(8):104773
pubmed: 35992091
ACS Nano. 2019 Apr 23;13(4):4049-4063
pubmed: 30912923
Int J Mol Sci. 2021 Jan 09;22(2):
pubmed: 33435371
J Biol Chem. 2008 Feb 8;283(6):3050-3058
pubmed: 18079119
Support Care Cancer. 2020 Jul;28(7):3303-3311
pubmed: 31758326
J Cell Physiol. 2019 Nov;234(11):20915-20924
pubmed: 31012106
Biochem Biophys Res Commun. 2020 Apr 2;524(2):418-423
pubmed: 32007276
Invest New Drugs. 2020 Aug;38(4):1129-1136
pubmed: 31701429
J Clin Invest. 2011 Jun;121(6):2350-60
pubmed: 21555851
Stem Cell Rev Rep. 2021 Apr;17(2):616-627
pubmed: 33078278
Neuroradiology. 2017 Apr;59(4):419-421
pubmed: 28303374
Tumour Biol. 2021;43(1):37-55
pubmed: 33935122
Int J Nanomedicine. 2020 Dec 03;15:9703-9715
pubmed: 33299312
Biomed Pharmacother. 2019 Jan;109:1541-1546
pubmed: 30551406
Cell Death Dis. 2017 Jul 13;8(7):e2921
pubmed: 28703809
Immunopharmacol Immunotoxicol. 2018 Apr;40(2):107-116
pubmed: 29405080
Nanomaterials (Basel). 2021 May 12;11(5):
pubmed: 34066096
Cancer Manag Res. 2020 Dec 04;12:12519-12526
pubmed: 33304106
Phytomedicine. 2019 Feb 15;54:140-148
pubmed: 30668363
Biol Pharm Bull. 2017;40(6):751-757
pubmed: 28566619
Eur J Cancer. 2008 Nov;44(16):2425-32
pubmed: 18789680
Nat Commun. 2020 Oct 6;11(1):5015
pubmed: 33024120
Clin Exp Pharmacol Physiol. 2019 Feb;46(2):126-136
pubmed: 30251267
Spec Care Dentist. 2019 Mar;39(2):166-172
pubmed: 30761565
Clin Cancer Res. 2008 Jul 15;14(14):4491-9
pubmed: 18628464
Int Immunopharmacol. 2022 Sep;110:108965
pubmed: 35764017
Cancer Prev Res (Phila). 2017 May;10(5):298-307
pubmed: 28325826
Int Immunopharmacol. 2019 May;70:110-116
pubmed: 30798159
Molecules. 2020 Dec 27;26(1):
pubmed: 33375458
Cell. 2013 Apr 11;153(2):320-34
pubmed: 23582323
Angew Chem Int Ed Engl. 2020 Jul 13;59(29):12062-12068
pubmed: 32304346
Adv Exp Med Biol. 2021;1328:1-9
pubmed: 34981467
Clin Transl Oncol. 2019 Apr;21(4):489-498
pubmed: 30293230
Invest New Drugs. 2012 Aug;30(4):1289-301
pubmed: 21547369
J Exp Clin Cancer Res. 2019 May 21;38(1):207
pubmed: 31113439
Cancer Sci. 2009 Nov;100(11):2210-7
pubmed: 19671059
Cancer Res. 2003 Nov 1;63(21):7526-9
pubmed: 14612555
Am J Gastroenterol. 2022 Jun 1;117(6):884-894
pubmed: 35213393
Molecules. 2018 Aug 18;23(8):
pubmed: 30126206
Curr Top Med Chem. 2016;16(22):2453-63
pubmed: 26873192
Nature. 2006 Sep 21;443(7109):350-4
pubmed: 16921384
Nat Rev Clin Oncol. 2022 Jan;19(1):37-50
pubmed: 34580473
Cancer Lett. 2022 Jul 1;537:215591
pubmed: 35398530
Bioorg Chem. 2020 Jan;95:103451
pubmed: 31927333
Ann Transl Med. 2021 Sep;9(17):1381
pubmed: 34733933
Biomed Pharmacother. 2019 Oct;118:109217
pubmed: 31302424
Int J Oncol. 2009 Oct;35(4):867-72
pubmed: 19724924
Front Immunol. 2018 Nov 27;9:2762
pubmed: 30538709
EBioMedicine. 2014 Nov 15;2(1):82-90
pubmed: 26137537
Mol Oncol. 2020 Dec;14(12):2994-3006
pubmed: 33179413
Sci Rep. 2016 Mar 16;6:23135
pubmed: 26979487
J Cancer. 2019 Jun 2;10(13):3012-3020
pubmed: 31281478
Cancer Sci. 2020 Dec;111(12):4326-4335
pubmed: 33006786
Evid Based Complement Alternat Med. 2016;2016:2905127
pubmed: 28096884
Clin Cancer Res. 2016 Jun 15;22(12):3005-15
pubmed: 26763251
Molecules. 2021 Mar 10;26(6):
pubmed: 33801973
Cancer Sci. 2011 May;102(5):1045-51
pubmed: 21272158
Molecules. 2021 Dec 04;26(23):
pubmed: 34885950
Molecules. 2020 Feb 05;25(3):
pubmed: 32033326
J Exp Med. 1995 Aug 1;182(2):459-65
pubmed: 7543139
Nat Rev Clin Oncol. 2019 Jun;16(6):356-371
pubmed: 30705439
J Control Release. 2021 Jan 10;329:434-444
pubmed: 33290796
DNA Cell Biol. 2014 Jul;33(7):418-25
pubmed: 24720675
Oncogenesis. 2020 Nov 9;9(11):100
pubmed: 33168807
Environ Toxicol. 2017 Feb;32(2):550-568
pubmed: 26990902
J Tradit Complement Med. 2016 Jun 15;7(2):205-233
pubmed: 28417091
Postgrad Med J. 2007 May;83(979):338-43
pubmed: 17488865
Breast Cancer (Dove Med Press). 2021 Jul 16;13:447-457
pubmed: 34295188
Cancer Prev Res (Phila). 2017 Jun;10(6):363-370
pubmed: 28400479
BMC Complement Altern Med. 2019 Aug 14;19(1):216
pubmed: 31412862
J Ethnopharmacol. 2013 Sep 16;149(2):576-82
pubmed: 23899453
Mol Cancer. 2020 Sep 24;19(1):145
pubmed: 32972405
Am J Transl Res. 2019 Jun 15;11(6):3750-3760
pubmed: 31312385
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1159-69
pubmed: 16775176
Int Immunopharmacol. 2013 Nov;17(3):850-7
pubmed: 24103581
J Nanobiotechnology. 2021 Nov 21;19(1):381
pubmed: 34802453
Life Sci. 2022 Feb 1;290:120266
pubmed: 34968467
J BUON. 2020 May-Jun;25(3):1330-1336
pubmed: 32862573
Phytomedicine. 2022 Jul 20;102:154217
pubmed: 35660350
Oncotarget. 2016 Nov 15;7(46):76076-76086
pubmed: 27738318
Radiat Res. 2015 Nov;184(5):509-17
pubmed: 26488756
Nutr Cancer. 2010;62(8):1137-41
pubmed: 21058202
Radiother Oncol. 2019 Aug;137:186-191
pubmed: 30898322
BMB Rep. 2019 Aug;52(8):520-524
pubmed: 31383247
Proc Natl Acad Sci U S A. 2020 May 5;117(18):9964-9972
pubmed: 32312817
BMC Complement Altern Med. 2006 Mar 17;6:10
pubmed: 16545122
Cell Death Dis. 2013 Dec 05;4:e948
pubmed: 24309935
Nutrients. 2018 Dec 06;10(12):
pubmed: 30563268
J Gastrointest Surg. 2016 Jan;20(1):13-23; discussion 23-4
pubmed: 26503259
Nat Rev Dis Primers. 2015 Nov 05;1:15065
pubmed: 27189416
Cancer Prev Res (Phila). 2017 Dec;10(12):710-718
pubmed: 28904061
Clin Immunol. 2018 Mar;188:103-112
pubmed: 29330114
JAMA Dermatol. 2022 Jul 1;158(7):779-786
pubmed: 35648426
Apoptosis. 2021 Dec;26(11-12):639-656
pubmed: 34743246
Oncol Lett. 2017 Mar;13(3):1880-1884
pubmed: 28454338
Biomed Pharmacother. 2022 Dec;156:113890
pubmed: 36270255
Cancer Chemother Pharmacol. 2018 Oct;82(4):695-706
pubmed: 30074076
Phytother Res. 2019 May;33(5):1413-1425
pubmed: 30873702
Oncology. 2016;90(2):69-78
pubmed: 26771576
Sci Transl Med. 2018 Jul 18;10(450):
pubmed: 30021886
J Med Food. 2020 Jan;23(1):43-49
pubmed: 31747326
J Clin Invest. 2013 Feb;123(2):787-99
pubmed: 23348740
Biochem Pharmacol. 2006 Nov 30;72(11):1547-54
pubmed: 16959222
Biomed Pharmacother. 2017 May;89:864-874
pubmed: 28282788
Cancer Sci. 2021 Dec;112(12):4844-4852
pubmed: 34529884
Oncol Rep. 2021 May;45(5):
pubmed: 33760192
Cancer Med. 2021 Apr;10(7):2332-2340
pubmed: 33666378
Int J Toxicol. 2015 Nov-Dec;34(6):543-50
pubmed: 26405269
Mol Med Rep. 2016 Jan;13(1):153-9
pubmed: 26531258
J Drug Target. 2017 Mar;25(3):247-254
pubmed: 27677346
ChemMedChem. 2020 Aug 5;15(15):1473-1479
pubmed: 32374071
Cancer. 2018 Jan 15;124(2):271-277
pubmed: 28960263
Drug Des Devel Ther. 2020 May 12;14:1813-1823
pubmed: 32494123
Cancer Prev Res (Phila). 2021 May;14(5):573-580
pubmed: 33648940
Integr Cancer Ther. 2015 Jan;14(1):65-74
pubmed: 25411208
Biochem Biophys Res Commun. 2021 Apr 23;550:70-76
pubmed: 33689882
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
Oncotarget. 2017 Jul 11;8(28):45133-45142
pubmed: 28415830
BMC Complement Altern Med. 2016 Aug 24;16(1):311
pubmed: 27558166
Am J Transl Res. 2021 Jan 15;13(1):57-72
pubmed: 33527008
Biochem Pharmacol. 2020 Jun;176:113824
pubmed: 31987852
Breast Cancer Res. 2016 Jan 26;18(1):10
pubmed: 26810608
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
Cancers (Basel). 2022 Sep 19;14(18):
pubmed: 36139697
Biomarkers. 2020 Dec;25(8):701-710
pubmed: 33048613
Acta Pharm Sin B. 2020 Dec;10(12):2299-2312
pubmed: 33354502
Molecules. 2021 Oct 15;26(20):
pubmed: 34684819
J Neurooncol. 2019 Jul;143(3):429-436
pubmed: 31152305
J Natl Cancer Inst. 2004 Apr 21;96(8):621-8
pubmed: 15100340
Phytomedicine. 2019 Sep;62:152953
pubmed: 31128486
Nanomaterials (Basel). 2021 Feb 03;11(2):
pubmed: 33546151
J Cell Physiol. 2021 Jan;236(1):193-204
pubmed: 32495392
Clin Cancer Res. 2021 Sep 15;27(18):4953-4973
pubmed: 33888488
J Immunother Cancer. 2019 Mar 28;7(1):85
pubmed: 30922400
Iran J Pharm Res. 2021 Spring;20(2):57-67
pubmed: 34567146
Nutrients. 2022 Feb 09;14(4):
pubmed: 35215376
BMC Syst Biol. 2014 Jul 07;8:82
pubmed: 25000828
Semin Plast Surg. 2021 Aug;35(3):181-188
pubmed: 34526866
Int J Mol Sci. 2019 May 01;20(9):
pubmed: 31052469
Front Oncol. 2022 Jun 23;12:891652
pubmed: 35814435
Nutrients. 2020 Apr 10;12(4):
pubmed: 32290071
J Int Med Res. 2021 Nov;49(11):3000605211009494
pubmed: 34755560
Int J Mol Sci. 2021 Nov 30;22(23):
pubmed: 34884812
Cancer Prev Res (Phila). 2010 Aug;3(8):985-93
pubmed: 20628004
J Clin Oncol. 2018 Apr 1;36(10):942-950
pubmed: 29394125
Arch Pharm Res. 2015 Jun;38(6):1195-203
pubmed: 25370606
J Urol. 2015 Mar;193(3):1016-22
pubmed: 25229559
Neoplasia. 2014 Jan;16(1):31-42
pubmed: 24563618
Ann Oncol. 2017 Dec 01;28(12):3044-3050
pubmed: 28950298
Cancer Manag Res. 2019 Dec 24;11:10731-10747
pubmed: 31920383
Drug Des Devel Ther. 2020 Jan 15;14:185-194
pubmed: 32021103
J Immunother Cancer. 2018 Dec 4;6(1):139
pubmed: 30526667
Oncotarget. 2017 Jul 18;8(41):71206-71222
pubmed: 29050357
Phytomedicine. 2019 Sep;62:152962
pubmed: 31132755
Front Immunol. 2020 Oct 22;11:582657
pubmed: 33193391
Cell Signal. 2021 Dec;88:110167
pubmed: 34628002
Oncogenesis. 2017 Oct 2;6(10):e384
pubmed: 28967875
J Biol Chem. 2014 Nov 21;289(47):32671-81
pubmed: 25294877
J Cancer. 2017 Jun 5;8(9):1679-1689
pubmed: 28775788
Asia Pac J Clin Nutr. 2017;26(4):606-612
pubmed: 28582808
Biochem Pharmacol. 2021 Jun;188:114575
pubmed: 33887260
Arch Biochem Biophys. 2020 Nov 30;695:108620
pubmed: 33038311
J Exp Clin Cancer Res. 2021 Jun 9;40(1):190
pubmed: 34108030
Prostate. 2019 May;79(6):614-621
pubmed: 30671976
Biomaterials. 2021 Apr;271:120716
pubmed: 33621894
J Ethnopharmacol. 2011 Oct 11;137(3):1283-90
pubmed: 21840388
Asia Pac J Oncol Nurs. 2019 Apr-Jun;6(2):154-160
pubmed: 30931360
Cancer Immunol Res. 2016 May;4(5):390-9
pubmed: 26980599
ACS Omega. 2021 Apr 13;6(16):10645-10654
pubmed: 34056218
Panminerva Med. 2014 Sep;56(3):211-20
pubmed: 24352031
Cancer Lett. 1997 May 1;115(1):73-9
pubmed: 9097981
Int J Mol Sci. 2018 Nov 05;19(11):
pubmed: 30400561
Arzneimittelforschung. 1996 Feb;46(2):196-200
pubmed: 8720313
Pharmacol Res. 2018 Jun;132:72-79
pubmed: 29614381
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
Leuk Res. 2017 Nov;62:98-103
pubmed: 29031126
Int J Radiat Biol. 2018 Sep;94(9):798-808
pubmed: 29939076
Int J Mol Sci. 2017 Jul 24;18(7):
pubmed: 28737711
Eur J Med Chem. 2019 Aug 15;176:378-392
pubmed: 31121546
J Ethnopharmacol. 2019 May 23;236:466-473
pubmed: 30853648
Chin J Nat Med. 2019 May 20;17(5):331-336
pubmed: 31171267
J Leukoc Biol. 2020 Jul;108(1):253-266
pubmed: 32272506
Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):117-25
pubmed: 23527714
Cancer Prev Res (Phila). 2015 Oct;8(10):879-87
pubmed: 25873370
Cancer Gene Ther. 2019 Nov;26(11-12):356-365
pubmed: 30651591
Front Pharmacol. 2019 Dec 06;10:1469
pubmed: 31866868